Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials
IF 3.4 3区 医学Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Emre Kara , Betul Okuyan , Cansu Goncuoglu , Kutay Demirkan , Shusen Sun
{"title":"Impact of pharmacist-led interventions on economic, clinical, and humanistic outcomes (ECHO) in patients admitted to emergency departments: A systematic review of randomized controlled trials","authors":"Emre Kara , Betul Okuyan , Cansu Goncuoglu , Kutay Demirkan , Shusen Sun","doi":"10.1016/j.sapharm.2025.10.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The role of pharmacists in emergency departments (EDs) has undergone a significant transformation globally, expanding beyond traditional responsibilities to include various clinical activities that promise to enhance patient outcomes. However, the full potential of these interventions, particularly from economic, clinical, and humanistic (ECHO) perspectives, remains to be systematically explored. The aim of this study was to evaluate the impact of pharmacist-led interventions on ECHO among patients admitted to the ED.</div></div><div><h3>Methods</h3><div>This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were conducted in PubMed, MEDLINE, and International Pharmaceutical Abstracts, focusing on randomized controlled trials (RCTs) published in English that involved pharmacist interventions in EDs. Data were extracted on study design, pharmacist interventions, and patient outcomes. Cochrane risk-of-bias tool for randomized trials (RoB 2.0) was used.</div></div><div><h3>Results</h3><div>Twelve RCTs that met the inclusion criteria were identified. The studies were conducted predominantly in tertiary care settings in various countries. The most common interventions performed by pharmacists included medication reconciliation, obtaining medication histories, and patient education. The review showed that pharmacist interventions tend to improve medication safety and patient satisfaction but varied significantly in their execution and reported outcomes. No studies comprehensively analyzed economic outcomes, and only a few addressed humanistic outcomes.</div></div><div><h3>Conclusions</h3><div>Pharmacy-led services improved clinical outcomes, however there was lack of studies showing the economic and humanistic outcomes of these services. The need for standardized protocols and further research to establish their broader impacts should be considered. The findings support the continued integration and expansion of pharmacist roles in emergency care, which could influence global policy and practice in healthcare systems.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 222-231"},"PeriodicalIF":3.4000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125004759","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The role of pharmacists in emergency departments (EDs) has undergone a significant transformation globally, expanding beyond traditional responsibilities to include various clinical activities that promise to enhance patient outcomes. However, the full potential of these interventions, particularly from economic, clinical, and humanistic (ECHO) perspectives, remains to be systematically explored. The aim of this study was to evaluate the impact of pharmacist-led interventions on ECHO among patients admitted to the ED.
Methods
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were conducted in PubMed, MEDLINE, and International Pharmaceutical Abstracts, focusing on randomized controlled trials (RCTs) published in English that involved pharmacist interventions in EDs. Data were extracted on study design, pharmacist interventions, and patient outcomes. Cochrane risk-of-bias tool for randomized trials (RoB 2.0) was used.
Results
Twelve RCTs that met the inclusion criteria were identified. The studies were conducted predominantly in tertiary care settings in various countries. The most common interventions performed by pharmacists included medication reconciliation, obtaining medication histories, and patient education. The review showed that pharmacist interventions tend to improve medication safety and patient satisfaction but varied significantly in their execution and reported outcomes. No studies comprehensively analyzed economic outcomes, and only a few addressed humanistic outcomes.
Conclusions
Pharmacy-led services improved clinical outcomes, however there was lack of studies showing the economic and humanistic outcomes of these services. The need for standardized protocols and further research to establish their broader impacts should be considered. The findings support the continued integration and expansion of pharmacist roles in emergency care, which could influence global policy and practice in healthcare systems.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.